Mental Health Daily

1 mg Guanfacine for Self-Harm Thoughts in ADHD-PTSD-BPD Case

by GLOOM

MHD featured image for 1 mg guanfacine and self-harm thoughts in complex ADHD, PTSD, BPD, and ASD comorbidity.

A 2026 case report linked 1 mg nightly guanfacine modified-release to first-ever cessation of intrusive deliberate self-harm thoughts in a 16-year-old with attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) traits, borderline personality disorder (BPD) traits, and post-traumatic stress disorder (PTSD). The same case became more interesting after the patient stopped taking guanfacine and the self-harm …

IV Clomipramine Shows No Clear Edge in Depression or OCD

by GLOOM

Photoreal illustration of an IV infusion bag and capsule with brain imagery, conveying parenteral vs oral antidepressant pharmacokinetics.

Parenteral clomipramine has a strong clinical myth around it: bypass the gut, raise parent-drug exposure quickly, and maybe accelerate rescue in severe depression or OCD. A 2026 systematic review found the route advantage was not clearly proven: in depression, 5 RCTs without high risk of bias did not show clear IV or IM superiority over …

Friedreich Ataxia MRI Study Finds 3 Progression Subtypes

by GLOOM

Photoreal illustration of brain regions affected in Friedreich ataxia with overlay of MRI imaging modalities, conveying multi-pattern subtypes.

A 2026 longitudinal MRI preprint involving 54 people with Friedreich ataxia and 57 controls found 3 biologically interpretable progression subtypes: microstructure-dominant, macrostructure-dominant, and minimal/no progression.1 The clusters make biomarker heterogeneity visible at the research level, while the classifier remains too early to assign individual patients to treatment paths. Research Highlights 3 MRI progression subtypes emerged: …

Only 5 of 50 NHS Trusts Could Count Psychiatric Inpatient Parents

by GLOOM

Photoreal illustration of a family room in psychiatric inpatient setting, conveying parent-child connection during parental hospitalization.

A 2026 Freedom of Information survey of all 50 English NHS trusts providing inpatient psychiatric care found a basic visibility failure: only 5 trusts could say how many psychiatric inpatients were parents, only 11 could describe routine parental-status data collection, and only 1 held child-visit data.1 Research Highlights Parent counts were mostly unavailable: 5 of …

Migrant Stroke Patients Had 1.90x Higher Late-Arrival Odds

by GLOOM

Photoreal illustration of a stroke patient in an emergency room with overlay of treatment-eligibility imagery, conveying disparities in acute-stroke care.

A 2026 Dutch stroke-center cohort found the opposite of the damaged draft’s claim: patients with a migration background were more likely to reach the hospital outside the therapeutic window for acute reperfusion therapy, and they had sharply lower odds of receiving endovascular thrombectomy.1 Research Highlights Late arrival was the clearest disparity: 53.2% of migrant-background patients …

Anxious Depression fMRI Meta-Analysis Finds Left Temporal Activation

by GLOOM

Editorial brain-map card for anxious depression with highlighted limbic and prefrontal regions from an earlier draft framing.

A 2026 fMRI meta-analysis of 11 studies found a narrow anxious-depression signal: 829 anxious-depression patients differed from 681 non-anxious MDD patients in left middle temporal gyrus activation (SDM-Z = 2.046, p = 0.020), while healthy-control contrasts centered on the anterior commissure and right middle frontal gyrus. The calibrated interpretation is not “amygdala and insula hyperactivity …

Dexamethasone Disrupts Mouse Sleep Through Orexin Hyperarousal

by GLOOM

Photoreal illustration of a steroid pill bottle with overlay of disrupted sleep architecture, conveying glucocorticoid-induced insomnia mechanism.

A 2026 male-mouse study found that 30 mg/kg dexamethasone for 5 days increased light-phase wakefulness (t13 = 4.122, p = 0.0012), decreased NREM sleep (t13 = 4.412, p = 0.0007), and amplified orexin-neuron activity during NREM-to-wake transitions (F1,9 = 6.941, p = 0.0272). The result points to orexin-linked hyperarousal as a testable explanation for steroid-induced …